BSE filing, BSE: 544630. Summary written from the filing by ALFA Finder's alert engine.
Helloji Holidays Ltd: key numbers
- Share price
- ₹114.00
- Market cap
- ₹39.10 Cr
- Revenue (annual)
- ₹27.66 Cr
- Net profit (annual)
- ₹1.25 Cr
- P/E (TTM)
- 31.2×Sector 34.0×
- Promoter holding
- 69.97%
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Helloji Holidays Ltd
All →Helloji Holidays Board Meeting Date
Helloji Holidays schedules a board meeting on November 5, 2026 to approve half-year unaudited results. Trading window remains closed until November 9, 2026.
Helloji Holidays Annual General Meeting
Helloji Holidays Ltd announced the voting results for its Annual General Meeting held on September 18, 2026. Shareholders approved all seven resolutions presented.
Helloji Holidays Annual General Meeting
Helloji Holidays concluded its 15th AGM on September 18, 2026, passing all ordinary and special resolutions, including re-appointments and managerial remuneration approval.
Helloji Holidays Annual General Meeting
Helloji Holidays Limited issued the notice for its 15th Annual General Meeting scheduled for September 18, 2026, including the Annual Report for FY 2025-2026.
Helloji Holidays H2 FY26 Results: Net Profit ₹0.3 Cr, Down 81.2% YoY
Helloji Holidays Ltd reported revenue from operations of ₹15 Cr (-10.2% YoY) and net profit of ₹0.3 Cr (-81.2% YoY) for H2 FY26.
- Key figure
- Net profit ₹0.3 Cr · -81.2% YoY
Helloji Holidays Financial Results
Helloji Holidays Ltd reported Audited Financial Results for FY26 with a Total Income of ₹27.86 Crore. The Board also appointed new secretarial and internal auditors.
- Value
- ₹27.86 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.